Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

A Phase 3 trial is planned to evaluate the efficacy and safety of ORMD-0801 in adults with type 2 diabetes mellitus, and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ORMD-0801

Snippet

Sponsor: Oramed, Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: NOT_YET_RECRUITING